Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TelyRx HoldingsTSX:TELY +13.04%12 PB Ratio is 3.59 as of Jul. 31, 2026, which is 6% below its 10-year median of 3.83. GuruFocus rates TSX:TELY with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 608 Healthcare Providers & Services companies, TelyRx Holdings ranks worse than 72.2% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-31), TelyRx Holdings's share price is C$2.60. TelyRx Holdings's Book Value per Share for the quarter that ended in Mar. 2026 was C$0.72. Hence, TelyRx Holdings's PB Ratio of today is 3.59.
The historical rank and industry rank for TelyRx Holdings's PB Ratio or its related term are showing as below:
TSX:TELY'
s PB Ratio Range Over the Past 10 Years
Min: 3.04 Med: 3.83 Max: 4.53
Current: 3.59
During the past 3 years, TelyRx Holdings's highest PB Ratio was 4.53. The lowest was 3.04. And the median was 3.83.
TSX:TELY's PB Ratio is ranked worse than 72.2% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 2.03
vs TSX:TELY: 3.59
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
TelyRx Holdings PB Ratio Related Terms
TelyRx Holdings PB Ratio Historical Data
* Premium members only.
The historical data trend for TelyRx Holdings's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, TelyRx Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TelyRx Holdings PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TelyRx Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where TelyRx Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
TelyRx Holdings's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
TelyRx Holdings (TSX:TELY) has a PB Ratio of 3.59 as of Jul. 31, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on TelyRx Holdings and its competitors. This is near median its historical median of 3.83. Over the past decade, TelyRx Holdings' PB Ratio has ranged from 3.04 to 4.53. According to the industry distribution chart, TelyRx Holdings ranks #439 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 72.2%.
Is TelyRx Holdings' PB Ratio too high?
TelyRx Holdings' current PB Ratio of 3.59 is near median its 10-year median of 3.83. Over the past 10 years, this metric has ranged from a low of 3.04 to a high of 4.53. The Healthcare Providers & Services industry median PB Ratio is 2.03. TelyRx Holdings' value of 3.59 is 76.8% above this industry median. Based on the distribution chart, TelyRx Holdings ranks #439 out of 608 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, TelyRx Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TelyRx Holdings' PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, TelyRx Holdings ranks #439 out of 608 companies for PB Ratio. This places TelyRx Holdings in the lower half of its industry. The industry median PB Ratio is 2.03. TelyRx Holdings' value of 3.59 is 76.8% above this benchmark. Historically, TelyRx Holdings' own PB Ratio has ranged from 3.04 to 4.53 over the past decade. While the company's 10-year median is 3.83 vs. the industry median of 2.03, TelyRx Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.03, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TelyRx Holdings's current PB Ratio of 3.59 is 76.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on TelyRx Holdings and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TelyRx Holdings's current PB Ratio is 3.59, which is near median its own 10-year median of 3.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TelyRx Holdings stock overvalued right now?
TelyRx Holdings (TSX:TELY) has a current PB Ratio of 3.59. The current PB Ratio is 3.59, which is near median its 10-year median of 3.83 and 76.8% above the Healthcare Providers & Services industry median of 2.03. TelyRx Holdings' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For TelyRx Holdings (TSX:TELY), the current PB Ratio is 3.59 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TelyRx Holdings Inc is a vertically integrated technology enabled healthcare and pharmacy services provider, operating a digital pharmacy platform that connects patients with independent, state-licensed providers. The TelyRx platform provides the Providers with access to a clinically focused electronic medical records system and the ability for them to electronically prescribe. TelyRx enables patient access to a risk-curated formulary of over 450 noncontrolled, and non-compounded prescription medications selected by the Providers to address a broad cross-section of everyday chronic and acute ailments.
12GF Score
Get the complete analysis for TSX:TELY
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:TELY has been successfully added to your 
